Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ALLO compared with ACHV: revenue, margins and what each company keeps, and the suppliers and customers both name
ALLO
Allogene Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ACHV
Achieve Life Sciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ALLO
Allogene Therapeutics, Inc.
vs
ACHV
Achieve Life Sciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ALLO
Allogene Therapeutics, Inc.
Change
1.13
▲
+3.67%
Mkt cap
$376.6M
Revenue
$5M
Q2 FY26
ACHV
Achieve Life Sciences, Inc.
Change
6.70
▲
+1.37%
Regular session
Nov 3 '26
Mkt cap
$702.8M
Revenue
—
vs
Compare
Regular session
Nov 3 '26
ALLO
Allogene Therapeutics, Inc.
vs
ACHV
Achieve Life Sciences, Inc.
1.13
▲
+3.67%
Price
6.70
▲
+1.37%
$376.6M
Mkt cap
$702.8M
Q2 FY26
$5M
Revenue
—
Change
Change
ALLO
1.13
▲
+3.67%
vs
ACHV
6.70
▲
+1.37%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ALLO: latest quarter is a loss; flow not drawable. ACHV: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ALLO
12
PFE
Pfizer
supplier
NTRA
Natera
supplier
CLLS
Cellectis
supplier
—
Arbor Biotechnologies
unlisted
supplier
8 more · ALLO chain
›
Shared
0
No shared counterparties.
Only ACHV
4
—
Sopharma, AD
unlisted
supplier
—
University of Bristol
unlisted
supplier
—
Adare Pharma Solutions
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Kristen Slaoui
unlisted
supplier
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ALLO, solid
ACHV, dashed